The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers

American Journal of Clinical Nutrition

Volumn 90, Issue 4, 2009, Pages 1029-1037

  Setchell, Kenneth D R ^a   Zhao, Xueheng ^a   Jha, Pinky ^a   Heubi, James E ^a,b   Brown, Nadine M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANDROGEN; CARBON 13; EQUOL; ESTROGEN; ISOFLAVONE DERIVATIVE; STABLE ISOTOPE; PHYTOESTROGEN; PLANT EXTRACT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTEREOISOMER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG URINE LEVEL; ENANTIOMER; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY; BIOAVAILABILITY; BLOOD; COMPARATIVE STUDY; HALF LIFE TIME; INTESTINE ABSORPTION; ISOTOPE LABELING; MIDDLE AGED; SOYBEAN; STEREOISOMERISM; URINE;

ADULT; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION; ISOFLAVONES; ISOTOPE LABELING; MALE; MIDDLE AGED; PHYTOESTROGENS; PLANT EXTRACTS; SOY FOODS; SOYBEANS; STEREOISOMERISM; YOUNG ADULT;

EID: 70349784717     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.27981     Document Type: Article

References (61)

1. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KDR. The identification of the weak oestrogen equol [7-hydroxy-3-(4′-hydroxyphenyl) chroman] in human urine. Biochem J 1982;201: 353-357 (Pubitemid 12160165)
2. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984;40:569-578 (Pubitemid 14035518)
3. Setchell KDR, Brown NM, Zimmer-Nechemias L, et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002;76:447-453 (Pubitemid 34804071)
4. Brown NM, Setchell KDR. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest 2001;81:735-747
5. Thigpen JE, Haseman JK, Saunders HE, Setchell KDR, Grant MG, Forsythe DB. Dietary phytoestrogens accelerate the time of vaginal opening in immature CD-1 mice. Comp Med 2003;53:607-615
6. Thigpen JE, Setchell KDR, Padilla-Banks E, et al. Variations in phytoestrogen content between different mill dates of the same diet produces significant differences in the time of vaginal opening in CD-1 mice and F344 rats but not in CD Sprague-Dawley rats. Environ Health Perspect 2007;115:1717-1726
7. Gu L, House SE, Prior RL, et al. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr 2006;136: 1215-1221
8. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-3584 (Pubitemid 35435031)
9. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 2005;230:155-170 (Pubitemid 40293689)
10. Setchell KDR, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006;136:2188-2193
11. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998;217:335-339 (Pubitemid 28130682)
12. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut flora. Nutr Cancer 2000;36:27-32. (Pubitemid 30317832)
13. Lydeking-Olsen E, Beck-Jensen JE, Setchell KDR, Holm-Jensen T. Soymilk or progesterone for prevention of bone loss - a 2 year randomized, placebo-controlled trial. Eur J Nutr 2004;43:246-257 (Pubitemid 39222536)
14. Bolca S, Possemiers S, Herregat A, et al. Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J Nutr 2007;137:2242-2246 (Pubitemid 47529584)
15. Lampe JW, Skor HE, Li S, Wahala K, Howald WN, Chen C. Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavone equol in premenopausal women. J Nutr 2001;131:740-744 (Pubitemid 32199139)
16. Steer TE, Johnson IT, Gee JM, Gibson GR. Metabolism of the soybean isoflavone glycoside genistin in vitro by human gut bacteria and the effect of prebiotics. Br J Nutr 2003;90:635-642
17. Bonorden MJ, Greany KA, Wangen KE, et al. Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr 2004;58:1635-1642
18. Nettleton JA, Greany KA, Thomas W, Wangen KE, Adlercreutz H, Kurzer MS. Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr 2004;134:1998-2003. (Pubitemid 39031330)
19. Larkin TA, Price WE, Astheimer LB. Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet. Nutrition 2007;23:709-718
20. Ueno T, Uchiyama S. Identification of the specific intestinal bacteria capable of metabolising soy isoflavone to equol. Ann Nutr Metab 2001; 45:114 (abstr).
21. Uchiyama S, Ueno T, Kumemura M, Imaizumi K, Masaki K, Shimizu S, inventors; Otsuka Pharmaceutical Co, Ltd, assignee. Streptococcus and isoflavone-containing composition. US patent 6,716,424 B1. 2004.
22. Wang XL, Hur HG, Lee JH, Kim KT, Kim SI. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol 2005;71:214-219
23. Decroos K, Eeckhaut E, Possemiers S, Verstraete W. Administration of equol-producing bacteria alters the equol production status in the Simulator of the Gastrointestinal Microbial Ecosystem (SHIME). J Nutr 2006;136:946-952
24. Wang XL, Kim HJ, Kang SI, Kim SI, Hur HG. Production of phytoestrogen S-equol from daidzein in mixed culture of two anaerobic bacteria. Arch Microbiol 2007;187:155-160
25. Tamura M, Ohnishi-Kameyama M, Shinohara K. Lactobacillus gasseri: effects on mouse intestinal flora enzyme activity and isoflavonoids in the caecum and plasma. Br J Nutr 2004;92:771-776 (Pubitemid 39562155)
26. Zhou-Teng Y, Wen Y, Wei-Yun Z. Isolation and identification of equol-producing bacterial strains from cultures of pig faeces. FEMS Microbiol Lett 2008;282:73-80.
27. Yee S, Burdock GA, Kurata Y, et al. Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae. Food Chem Toxicol 2008;46:2713-2720
28. Cheng E, Yoder L, Story C, Burrough W. Estrogenic activity of some isoflavone derivatives. Science 1954;120:575-576
29. Shemesh M, Lindner H, Ayalon N. Affinity of rabbit uterine oestradiol receptor for phytoestrogens and its use in a competitive protein binding radioassay for plasma coumestrol. J Reprod Fertil 1972;29:1-9.
30. Shutt DA, Cox RI. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol 1972;52:299-310.
31. Morito K, Hirose T, Kinjo J, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001;24:351-356 (Pubitemid 32377601)
32. Kostelac D, Rechkemmer G, Briviba K. Phytoestrogens modulate binding response of estrogen receptors a and b to the estrogen response element. J Agric Food Chem 2003;51:7632-7635
33. Muthyala RS, Ju YH, Sheng S, et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004;12: 1559-1567 (Pubitemid 38304880)
34. Setchell KDR, Clerici C, Lephart ED, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005;81:1072-1079 (Pubitemid 41724948)
35. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 2004;70:1188-1195
36. Mitchell JH, Gardner P, McPhail D, Morrice P, Collins A, Duthie G. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 1998;360:142-148 (Pubitemid 29010923)
37. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 1998;356:133-141 (Pubitemid 28387717)
38. Setchell KDR, Sirokin V, inventors. Method for the enantioselective hydrogenation of chromenes. US patent 2007/0027329A1 and PCT WO 2007/016423A2. 2005.
39. 13C]daidzein. J Med Food 1999;2:99-102.
40. Nelson RE, Grebe SK, Okane DJ, Singh RJ. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 2004;50:373-384 (Pubitemid 38156379)
41. Axelson M, Setchell KDR. Conjugation of lignans in human urine. FEBS Lett 1980;122:49-53.
42. Axelson M, Sjovall J, Gustafsson BE, Setchell KDR. Soya - a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 1984;102:49-56. (Pubitemid 14123919)
43. Doerge DR, Chang HC, Churchwell MI, Holder CL. Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos 2000;28:298-307.
44. Ronis MJ, Little JM, Barone GW, Chen G, Radominska-Pandya A, Badger TM. Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract. J Med Food 2006;9:348-355 (Pubitemid 44850718)
45. Shelnutt SR, Cimino CO, Wiggins PA, Ronis MJ, Badger TM. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr 2002;76:588-594
46. Setchell KDR, Brown NM, Desai P, et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001;131:1362S-75S. (Pubitemid 32268489)
47. 13C]labeled tracers in premenopausal women. Am J Clin Nutr 2003;77:411-419
48. Izumi T, Piskula M, Osawa S, et al. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 2000;130:1695-1699 (Pubitemid 30451055)
49. Busby MG, Jeffcoat AR, Bloedon LT, et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 2002;75:126-136 (Pubitemid 34013498)
50. Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 2003;77:1459-1465 (Pubitemid 39655280)
51. King RA, Bursill D. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 1998;67:867-872 (Pubitemid 28196660)
52. Setchell KDR, Brown NM, Desai PB, et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003;133: 1027-1035
53. Piazza C, Privitera MG, Melilli B, et al. Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women. Am J Clin Nutr 2007;86:775-780 (Pubitemid 47435847)
54. Day AJ, DuPont MS, Ridley S, et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver betaglucosidase activity. FEBS Lett 1998;436:71-75 (Pubitemid 28454609)
55. Bloedon LT, Jeffcoat AR, Lopaczynski W, et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 2002;76:1126-1137 (Pubitemid 35244688)
56. Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998;128:209-213 (Pubitemid 28124988)
57. Chen Z, Zheng W, Custer LJ, et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1999;33:82-87 (Pubitemid 29196127)
58. Wakai K, Egami I, Kato K, et al. Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 1999;33:139-145 (Pubitemid 29270000)
59. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006;55:1-12. (Pubitemid 44477039)
60. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust J Agric Res 1946;22:131-138
61. Shutt DA, Braden AWH. The significance of equol in relation to the oestrogenic responses in sheep ingesting clover with a high formononetin content. Aust J Agric Res 1968;19:545-553